Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

• Status: Not yet recruiting
• Trial end date: 2029-12-01
• Target enrollment: 0
• Participant gender: All

Summary

ACEIs as treatment for COVID19

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Captopril; Chloroquine; Enalapril

Criteria

Inclusion Criteria:

• Patients infected with covid 19

Exclusion Criteria:

• allergy or contraindications to the drug